tradingkey.logo
tradingkey.logo
Buscar

Embecta Corp

EMBC
Añadir a la lista de seguimiento
3.350USD
-0.010-0.30%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
198.75MCap. mercado
1.75P/E TTM

Más Datos de Embecta Corp Compañía

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Información de Embecta Corp

Símbolo de cotizaciónEMBC
Nombre de la empresaEmbecta Corp
Fecha de salida a bolsaMar 21, 2022
Director ejecutivoKurdikar (Devdatt)
Número de empleados1850
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección300 Kimball Drive
CiudadPARSIPPANY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07054
Teléfono18624010000
Sitio Webhttps://www.embecta.com/
Símbolo de cotizaciónEMBC
Fecha de salida a bolsaMar 21, 2022
Director ejecutivoKurdikar (Devdatt)

Ejecutivos de Embecta Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
45.58K
+50.12%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
34.01K
-18.45%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
20.34K
-83.88%
Dr. Claire Pomeroy, M.D.
Dr. Claire Pomeroy, M.D.
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Embecta Corp?

Los cinco principales accionistas de Embecta Corp son: Mr. Devdatt (Dev) Kurdikar

¿Cuántas instituciones poseen acciones de Embecta Corp (EMBC)?

A fecha de 2026Q1, 791 instituciones poseen acciones de Embecta Corp, con un valor de mercado combinado de aproximadamente 59.40M, lo que representa el 100.13% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -4635325.00.

¿Cuál es la mayor fuente de ganancias de Embecta Corp?

El 2026Q1, el segmento empresarial Pen Needles generó la ganancia más alta para Embecta Corp, ascendiendo a 185.50M y representando el 71.02% de la ganancia total.